Gabelli Funds LLC Sells 20,104 Shares of Integer Holdings Co. (NYSE:ITGR)

Gabelli Funds LLC lessened its stake in Integer Holdings Co. (NYSE:ITGR - Free Report) by 23.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 64,000 shares of the medical equipment provider's stock after selling 20,104 shares during the period. Gabelli Funds LLC owned 0.19% of Integer worth $8,481,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of ITGR. Blue Trust Inc. lifted its stake in shares of Integer by 4.4% in the 4th quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider's stock valued at $220,000 after purchasing an additional 71 shares during the period. Arizona State Retirement System boosted its holdings in Integer by 0.9% during the fourth quarter. Arizona State Retirement System now owns 9,732 shares of the medical equipment provider's stock worth $1,290,000 after buying an additional 84 shares during the last quarter. HighPoint Advisor Group LLC grew its position in shares of Integer by 6.4% during the 4th quarter. HighPoint Advisor Group LLC now owns 1,684 shares of the medical equipment provider's stock worth $234,000 after buying an additional 101 shares during the period. Norden Group LLC increased its stake in shares of Integer by 7.0% in the 4th quarter. Norden Group LLC now owns 1,668 shares of the medical equipment provider's stock valued at $221,000 after acquiring an additional 109 shares during the last quarter. Finally, Corient Private Wealth LLC raised its position in shares of Integer by 6.4% in the 4th quarter. Corient Private Wealth LLC now owns 1,969 shares of the medical equipment provider's stock valued at $261,000 after acquiring an additional 118 shares during the period. Institutional investors and hedge funds own 99.29% of the company's stock.

Integer Stock Up 1.5 %

Shares of NYSE ITGR traded up $1.68 during mid-day trading on Tuesday, hitting $117.12. The company had a trading volume of 52,785 shares, compared to its average volume of 480,653. The company has a current ratio of 2.95, a quick ratio of 2.09 and a debt-to-equity ratio of 0.62. The firm has a 50-day simple moving average of $121.14 and a two-hundred day simple moving average of $130.50. The company has a market capitalization of $4.09 billion, a PE ratio of 34.86, a price-to-earnings-growth ratio of 1.72 and a beta of 1.09. Integer Holdings Co. has a one year low of $104.93 and a one year high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.46 by ($0.03). Integer had a return on equity of 11.65% and a net margin of 6.92%. The company had revenue of $449.50 million for the quarter, compared to the consensus estimate of $446.28 million. On average, equities analysts expect that Integer Holdings Co. will post 6.01 EPS for the current year.

Analyst Upgrades and Downgrades

ITGR has been the topic of several analyst reports. Oppenheimer lowered shares of Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st. Benchmark increased their price target on Integer from $140.00 to $150.00 and gave the stock a "buy" rating in a report on Friday, February 21st. Raymond James began coverage on Integer in a research report on Friday, March 28th. They issued an "outperform" rating and a $145.00 price objective for the company. Truist Financial dropped their target price on shares of Integer from $163.00 to $140.00 and set a "buy" rating on the stock in a report on Friday, April 11th. Finally, KeyCorp dropped their price objective on shares of Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a report on Monday. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, Integer presently has an average rating of "Moderate Buy" and an average price target of $145.00.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.